European Medicines Agency approved Pfizer booster shots for all adults
- ‘Most Expensive Drug’ Zolgensma facing new challenge after Two Children Died
- Hair loss and sexual dysfunction added to list of symptoms of long-COVID along with fatigue and brain fog
- Merck diabetes drug Sitagliptin was hit by carcinogenic impurities
- CDC relaxes and reiterates its COVID-19 guidance
- How does NOVAVAX solve the dilemma when COVID-19 vaccine sales plummeted by 90%?
- Scientists develop new antibiotic molecule that kills several superbugs
European Medicines Agency approved Pfizer COVID-19 booster shots for all adults
- A highly infectious disease that has been extinct for more than 40 years has appeared in New York
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
- Omicron new variant BA.2.75 has stronger infectivity than BA.4 and BA.5?
- Taiwan death from COVID-19 vaccination exceeds death from COVID-19
- The world top 5 best-selling drugs in 2020
European Medicines Agency approved Pfizer COVID-19 booster shots for all adults.
The European Medicines Agency (EMA) announced on October 4 that it is recommended to vaccinate the third dose of Pfizer’s COVID-19 vaccine for adults 18 years and older; and those with severely weakened immune systems can receive a third dose 28 days after the second dose-Injection of Pfizer or Moderna’s COVID-19 vaccine.
Humans are not the only ones who need the COVID-19 vaccine. Finland recently announced that it will vaccinate 2 million minks in the country’s farms with an experimental COVID-19 vaccine. This makes Finland the first country in the world to vaccinate animals against the COVID-19.
In addition to vaccines, there are also a number of anti-coronavirus drugs in clinical trials that have attracted much attention, especially the oral anti-coronavirus drug Molnupiravir of the US pharmaceutical giant Merck & Co. (MSD).
The European Medicines Agency approved the third injection of Pfizer for adults
The European Medicines Agency (EMA) announced on October 4 that it approved the third dose of Pfizer’s COVID-19 vaccine (Comirnaty) for adults 18 years and older. Studies have shown that “18 to 55-year-olds can increase their antibody levels by supplementing the booster shot 6 months after receiving the second dose of vaccine.”
▲ Screenshot of the European Medicines Agency’s Twitter.
The European Medicines Agency also stated that the evaluation of the Moderna vaccine booster is still in progress.
In addition, the European Medicines Agency also announced that groups with severely weakened immune systems can receive a third dose of Pfizer or Moderna vaccine 28 days after the second dose.
The statement said that studies on patients who have undergone organ transplantation show that the third booster needle can effectively improve the ability to produce antibodies.
Since August 30, France has opened the third vaccination to elderly people 65 years and older and people at high risk of severe COVID-19 disease. At present, 18 million people have received the booster vaccination.
The latest research in the United States shows that the adverse reaction of the third injection is similar to that of the second injection: 79% of people feel swelling and pain near the eye of the injection needle; 74% of people feel tired. The picture shows Pfizer’s COVID-19 vaccine Comirnaty.
European Medicines Agency approved Pfizer COVID-19 booster shots for all adults
(source:internet, reference only)
Disclaimer of medicaltrend.org
